Research Article| Volume 29, ISSUE 6, 104815, June 2020

Prediction of Persistent Impaired Glucose Tolerance in Patients with Minor Ischemic Stroke or Transient Ischemic Attack


      Background: Impaired glucose tolerance (IGT) in patients with ischemic stroke can return to normal, reflecting an acute stress response, or persist. Persistent IGT is associated with an increased risk of recurrent stroke, other cardiovascular diseases and unfavorable outcome after stroke. We aim to validate our previously developed model to identify patients at risk of persistent IGT in an independent data set, and, if necessary, update the model. Methods: The validation data set consisted of 239 nondiabetic patients with a minor ischemic stroke or TIA and IGT in the acute phase (2-hour post-load glucose levels between 7.8 and 11.0 mmol/l). The outcome was persistent versus normalized IGT, based on repeated oral glucose tolerance test after a median of 46 days. The discriminative ability of the original model was assessed with the area under the ROC curve (AUC). The updated model was internally validated with bootstrap resampling and cross-validated in the development population of the original model. Results: One-hundred eighteen of 239 (49%) patients had persistent IGT. The original model, with the predictors age, current smoking, statin use, triglyceride, hypertension, history of cardiovascular diseases, body mass index (BMI), fasting plasma glucose performed poorly (AUC .60). The newly developed model included only BMI, hypertension, statin use, atrial fibrillation, 2-hour post-load glucose levels, HbA1c, large artery atherosclerosis, and predicted persistent IGT more accurately (internally validated AUC 0.66, externally validated AUC .71). Conclusions: This prediction model with simple clinical variables can be used to predict persistent IGT in patients with IGT directly after minor stroke or TIA, and may be useful to optimize secondary prevention by early identification of patients with disturbed glucose metabolism.

      Key Words

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Journal of Stroke and Cerebrovascular Diseases
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Dave JA
        • Engel ME
        • Freercks R
        • et al.
        Abnormal glucose metabolism in non-diabetic patients presenting with an acute stroke: Prospective study and systematic review.
        Qjm. 2010; 103: 495-503
        • Jia Q
        • Zheng H
        • Liu L
        • et al.
        Persistence and predictors of abnormal glucose metabolisms in patients after acute stroke.
        Neurol Res. 2010; 32: 359-365
        • Vancheri F
        • Curcio M
        • Burgio A
        • et al.
        Impaired glucose metabolism in patients with acute stroke and no previous diagnosis of diabetes mellitus.
        Qjm. 2005; 98: 871-878
        • Fonville S
        • den Hertog HM
        • Zandbergen AAM
        • et al.
        Occurrence and predictors of persistent impaired glucose tolerance after acute ischemic stroke or transient ischemic attack.
        J Stroke Cerebrovasc Dis. 2014; 23: 1669-1675
        • Vermeer SE
        • Sandee W
        • Algra A
        • et al.
        Impaired glucose tolerance increases stroke risk in nondiabetic patients with transient ischemic attack or minor ischemic stroke.
        Stroke. 2006; 37: 1413-1417
        • Lee M
        • Saver JL
        • Hong K-S
        • et al.
        Effect of pre-diabetes on future risk of stroke: meta-analysis.
        Bmj. 2012; 344: e3564
        • Oizumi T
        • Daimon M
        • Jimbu Y
        • et al.
        Impaired glucose tolerance is a risk factor for stroke in a Japanese sample-the Funagata study.
        Metabolism. 2008; 57: 333-338
        • Jia Q
        • Liu G
        • Zheng H
        • et al.
        Impaired glucose regulation predicted 1-year mortality of Chinese patients with ischemic stroke: data from abnormal glucose regulation in Patients with acute stroke across China.
        Stroke. 2014; 45: 1498-1500
        • Adams HP
        • Bendixen BH
        • Kappelle LJ
        • et al.
        Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment.
        Stroke. 1993; 24: 35-41
        • American Diabetes Association
        2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes-2020.
        Diabetes Care. 2020; 43: S14-S31
        • Zou KH
        • O'Malley AJ
        • Mauri L
        Receiver-operating characteristic analysis for evaluating diagnostic tests and predictive models.
        Circulation. 2007; 115: 654-657
        • Urabe T
        • Watada H
        • Okuma Y
        • et al.
        Prevalence of abnormal glucose metabolism and insulin resistance among subtypes of ischemic stroke in Japanese patients.
        Stroke. 2009; 40: 1289-1295
        • Perreault L
        • Temprosa M
        • Mather KJ
        • et al.
        Regression from prediabetes to normal glucose regulation is associated with reduction in cardiovascular risk: Results from the diabetes prevention program outcomes study.
        Diabetes Care. 2014; 37: 2622-2631
        • Stefan N
        • Fritsche A
        • Schick F
        • et al.
        Phenotypes of prediabetes and stratification of cardiometabolic risk.
        Lancet Diabetes Endocrinol. 2016; 4: 789-798
        • Nichols GA
        • Hillier TA
        • Brown JB
        Progression from newly acquired impaired fasting glusose to Type 2 diabetes.
        Diabetes Care. 2007; 30: 228-233
        • Nordestgaard BG
        • Varbo A
        Triglycerides and cardiovascular disease.
        Lancet. 2014; 384: 626-635
        • Fonville S
        • Zandbergen AA
        • Vermeer SE
        • et al.
        Prevalence of prediabetes and newly diagnosed diabetes in patients with a transient ischemic attack or stroke.
        Cerebrovasc Dis. 2013; 36: 283-289
        • Haw JS
        • Galaviz KI
        • Straus AN
        • et al.
        Long-term sustainability of diabetes prevention approaches: A systematic review and meta-analysis of randomized clinical trials.
        JAMA Intern Med. 2017; 177: 1808-1817
        • Tabák AG
        • Herder C
        • Rathmann W
        • et al.
        Prediabetes: a high-risk state for diabetes development.
        Lancet. 2012; 379: 2279-2290
        • The DECODE study group
        Glucose tolerance and mortality: comparison of WHO and American Diabetic Association diagnostic criteria.
        Lancet. 1999; 354: 617-621
        • Bartnik M
        • Malmberg K
        • Norhammar A
        • et al.
        Newly detected abnormal glucose tolerance: an important predictor of long-term outcome after myocardial infarction.
        Eur Heart J. 2004; 25: 1990-1997
        • Osei E
        • Fonville S
        • Zandbergen AAM
        • et al.
        Glucose in prediabetic and diabetic range and outcome after stroke.
        Acta Neurol Scand. 2017; 135: 170-175
        • Kernan WN
        • Viscoli CM
        • Furie KL
        • et al.
        Pioglitazone after Ischemic Stroke or Transient Ischemic Attack.
        N Engl J Med. 2016; 374: 1321-1331
        • Osei E
        • Fonville S
        • Zandbergen AAM
        • et al.
        Metformin and sitAgliptin in patients with impAired glucose tolerance and a recent TIA or minor ischemic Stroke (MAAS): study protocol for a randomized controlled trial.
        Trials. 2015; 16: 1-6